View of Adverse Event Of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Treatment In Medan Among Pulmonary Adenocarcinoma: Focus On Non-Hematologic Toxicity

https://journal-hnups.com.ua/

https://penmaru.ummetro.id/

https://ebidmotor.org/

https://hellobacsi.org/

https://hoteldesartssaigon.org/

https://fapetunipa.com/

https://bunghatta.com/

https://golf-components.com/

https://italiannis.org/

https://ristorantelapiazza.org/

Return to Article Details Adverse Event Of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Treatment In Medan Among Pulmonary Adenocarcinoma: Focus On Non-Hematologic Toxicity Download Download PDF